Peter N. Laivins
Direttore/Membro del Consiglio presso GENEXINE, INC.
Profilo
Mr. Peter N.
Laivins is an Independent Director at Genexine, Inc. He is on the Board of Directors at Genexine, Inc. Mr. Laivins was previously employed as a Head-Development by Merrimack Pharmaceuticals, Inc. and a Vice President-Commercial & Strategic Marketing by Elan Biopharmaceuticals, Inc. He received his undergraduate degree from McGill University and an MBA from McGill University.
Posizioni attive di Peter N. Laivins
| Società | Posizione | Inizio |
|---|---|---|
| GENEXINE, INC. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Peter N. Laivins
| Società | Posizione | Fine |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2017 |
Elan Biopharmaceuticals, Inc.
 Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Vendite & Marketing | 01/01/2010 |
Formazione di Peter N. Laivins
| McGill University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENEXINE, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Elan Biopharmaceuticals, Inc.
Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Distribution Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Peter N. Laivins
